CCO Independent Conference Coverage: Clinical Impact of New HIV Data From CROI 2024 *

This program outlines important data and highlights from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI).

Share

Program Content

Capsule Summary Slides

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

*ProCE is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.